Phillips-Medisize announces expansion
Medical device company, Phillips-Medisize, has announced the expansion of its Global Innovation and Development (GID) site in Struer, Denmark.
The facility will have a dedicated manufacturing development and clinical build unit. This unit is scheduled to open in the second quarter of 2020.
The building will also be equipped to serve clients with agile set up for cleanroom assembly and moulding (e.g. for clinical trials). There will be approximately 500 m2 of floor space repurposed for the cleanroom from the existing 8400 m2 building. The facility is primarily designed to support late stage development of medium- and high-volume products and processes under good manufacturing practice.
John Horgan, vice president, global sales and marketing, Phillips-Medisize said: “This expansion accelerates the manufacture of innovative, compliant and best-in-class products while reducing time to market and lowering launch risk for drug delivery device customers.”
He added: “Furthermore, it strengthens our client focus in Scandinavia by complementing the activities of our existing GID in Struer and our newest GID in Copenhagen.”
Phillips-Medisize aims to provide a wide range of custom drug delivery devices, connected health solutions and end-to-end manufacturing services worldwide.